Kedudukan dalam Saham
#37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Harga Saham
$0.07
Disegerakkan terakhir: 2024-11-12
Perubahan (1 tahun)
0.00%
Perdagangan Peak Bio, Inc. (PKBO)
Harga PKBO dengan permodalan pasaran b
Modal pasaran bagi Peak Bio, Inc.(PKBO)
Modal Pasaran: $1.62M
Sehingga August 2026, Peak Bio, Inc. mempunyai modal pasaran sebanyak $1.62M. Ini menjadikan Peak Bio, Inc. syarikat ke-37553rd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Peak Bio, Inc. dari 2021 hingga 2026
PKBO berbanding dengan 5 teratas yang paling popular stocks
| Harga PKBO |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.452T
|
+336,854,984.03%
|
|
|
|
|
$4.490T
|
+277,425,214.66%
|
|
|
|
|
$4.162T
|
+257,182,948.93%
|
|
|
|
|
$3.676T
|
+227,150,429.30%
|
|
|
|
|
$2.833T
|
+175,045,381.37%
|
